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Organised cytological screening for cervical cancer 
has for long drastically reduced the incidence of the 
1, 2, 3
invasive disease and its mortality . And though 
invasive cervical cancer is now preventable, the 
global incidence stands at 500,000, with 233,000 
deaths per year, 80% of which occur in 
4, 5developing countries . Cervical cancer remains 
the commonest cause cancer deaths among women 
in developing countries, largely due to failure to 
6establish cytology based screening programs . Cost, 
inadequate manpower and ignorance are among 
various factors militating against this organised 
routine cytological screening. 
The difficulty in establishing routine cytological 
screening in low resource settings could be 
overcome reducing the burden of the population that 
 7
requires screening without comprising its benefits . 
This could be achieved through selective screening 
of high-risk patients in targeted screening programs 
8
. The high-risk group could be identified via a risk 
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scoring system for the targeted selective screening of 
those most like to develop the disease. 
There is overwhelming evidence that population 
cytological screening is effective in reducing 
2, 9morbidity and mortality from cervical cancer . It is 
also clear that competing health needs of developing 
countries cannot support routine population 
screening for cervical cancer in the foreseeable 
future. And while vaccines against HPV 16 and 18 
may be effective,many unanswered questions have 
to be clarified before it comes into large scale clinical 
use in developing countries. Thus the way out of the 
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ABSTRACT
Context: Cervical cancer is the leading cause of cancer related mortality in developing countries. The lack of 
routine cytological screening in developing countries is largely responsible for this high mortality. 
Objectives: To develop a risk score that would easily identify women at greater risk of having cervical intraepithelial 
neoplasia (CIN) for use in selective population screening.
Study Design, Setting and Subjects: This is a cross sectional study carried out in two tertiary institutions in Northern 
Nigeria.One thousand one hundred and twenty-nine women attending clinics at two Teaching Hospitals in Nigeria 
were randomly screened for CIN. Each had a pap smear taken for cytology after a questionnaire had been filled. 
Results: There were 1129 questionnaires administered during the study period. The mean age was 28.9±6.8 years. 
The majority, 61.9% had no formal education and 76.2% were unemployed housewives of low socio economic class. 
The risk factors that showed statistically significant relationship with CIN were number of marriages (OR = 12.6, 
P=0.006), polygamy (OR = 21.7,P=0.001), premarital coitus (OR = 30.0,P=0.001), coital frequency (OR = 
30.9,P=0.002), number of sexual partners (OR = 35.9,P=0.003), parity (OR = 51.4,P=0.001), coitarche (OR = 
52.8,P=0.020), age at first marriage (OR = 78.1,P=0.001) and age (OR = 107.9,P=0.001). 
Conclusion: Risk scoring can help filter those women at high risk of cervical neoplasia from history alone during 
clinic visits. This is particularly beneficial in resource poor settings with highly competing health demands, hence 
improving the sensitivity and specificity of screening by selectively targeting population at risk.
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(OR = 30.0,P=0.001), coital frequency (OR = 
30.9,P=0.002), number of sexual partners (OR = 
35.9,P=0.003), parity (OR = 51.4,P=0.001), 
coitarche (OR = 52.8,P=0.020), age at first marriage 
(OR = 78.1 ,P=0.001)  and age  (OR = 
107.9,P=0.001). The scale for scores based on the 
odd ratios ranged from 1-5 as demonstrated on table 
3. The greater the risk, the higher the score (table 4).  
There were eight risk factors with a total score of 0-
21, which are arbitrarily classified as low, medium 
or high risk as detailed on table 5 based on total 
scores <8, 8-16 and >16 respectively.
current impasse for developing countries is to 
develop effective methods of targeting high risk 
individuals to reduce the screening burden and 
improve the pick up rate for precursor lesions
OBJECTIVES
The objective of the study was to develop a risk 
score that would easily identify women at greater 
risk of having CIN for use in selective screening of 
targeted high risk population.
SUBJECTS AND METHODS
The subjects studied were sexually active women 
attending gynaecological clinics at the University of 
Maiduguri and Aminu Kano University Teaching 
Hospitals both in Northern Nigeria, who had their 
pap smears taken sporadically with an Ayre's 
spatula. 
The women were instructed to come for the 
procedure between 10 and 20 days after the first day 
of their menstrual periods. They were also advised 
to avoid douching, using spermicidal foams, creams 
or jellies for at least two days before the procedure to 
avoid washing away or hide any abnormal cells. In 
dorsal position, a bivalve speculum was used to 
expose the cervix after lubrication with water. Ayre's 
spatula was inserted into the cervical os and rotated 
360 degrees and then withdrawn. The samples were 
then spread evenly from both sides of the spatula 
and fixed immediately in 95% alcohol provided by 
the histopathology laboratory.
Staining technique used was Papanicolaou. 
Questionnaires were administered to each woman 
enquiring about her socio demographic, sexual and 
reproductive factors. The data collected were 
analysed on SPSS version 13.0 statistical software 
for odds ratio of all the risk factors for predicting 
CIN. The odds ratios were then classified into 5 
levels of score from 1-5. 
RESULTS
There were 1129 questionnaires administered 
during the study period.  Table 1 shows that 
majority, 67.8% of women who availed themselves 
to this opportunistic screening were under 30 years 
of age with a 70% illiteracy rate and 76% 
unemployment rate. In table 2, the risk factors 
studied are depicted. Their risk association with CIN 
are also shown in order of increasing statistical 
significance. The risk factors that showed 
statistically significant relationship with CIN were 
number of marriages (OR = 12.6, P=0.006), 




Table 1: Socio-demographic Characteristics









































































Table 2: Relationship between Risk Factors and CIN
Risk Factors Odds ratios P-values
Endocervical swab isolate 0.5 0.921 (NS)




























































Coitarche 52.8 0.020 (S)
Age at first marriage 78.1 0.001 (S)
Age 107.9 0.001 (S)
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Table 4: Differential Scores of Significant Risk Factors





<35 1  
36-50 2  
51-65 3  














































































Table 5: Classification of Risk factors Based on Scores
DISCUSSION
Where the majority of the populace are 
unenlightened and the limited resources available to 
government cannot cater for the health needs of the 
people, a selective screening of high risk women 
that is easily identifiable from the history is vital in 
minimizing waste without compromising benefits. 
The classification of women into low, medium and 
high risk based on the significant risk factors will 
help retain sufficient specificity to reduce the 
number of those screened. By selectively screening 
women with scores >16 (high risk), the limited 
resources will be targeted to those at greatest risk of 
2
cervical neoplasia.
All the significant risk factors identified in this study 
are known to be associated with cervical cancer. 
Perhaps there is no epidemiologic parameter so 
 9
studied as sexual activity.   The observation of 
significant association of sexual activity (coitarche, 
age at first marriage, premarital coitus, polygamy, 
number of marriages, coital frequency and number 
of sexual partners) are in keeping with earlier studies 
10-12. Studies using carcinoma in situ as an end point 
reported the association of increasing parity with 
13cervical neoplasia  . However recent studies have 
shown that the association of parity to cervical 
14neoplasia may be independent of HPV infection  . 
There is general agreement in the literature that 
older age is a strong determinant of cervical cancer 
15-17
. In an attempt to develop a risk scoring system 
for prediction of cervical cancer, an Indian study 
found illiteracy, poor genital hygiene, long duration 
of married life, multiparity and early menarche as 
risk factors significantly associated with cervical 
18
cancer  .
Despite the high false negative rate with Pap smear, 
the need for cytological screening in preventing 
invasive cancer of the cervix cannot be 
overemphasized. In Nordic countries where cervical 
screening services and modern tracking systems are 
well established, the incidence of invasive cervical 
2cancer has been reduced by 90 %   . However, in 
most  developing countries where cervical 
screening services are not well established, the 
19-21
majority of patients present with late disease . In 
these low resource settings screening is commonly 
not available and where available are located far 
from the reach of those that need the services most. 
Such unhealthy developments often lead to 
22
indiscriminate screening of women at low risk . To 
Total Scores Risk Classification  
<8 Low  
8-16 Medium  
>16 High  
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overcome the problems of poor coverage and cost of 
cervical cancer screening in developing countries 
several alternatives have been tried among which 
are visual inspection- aided and unaided, 
magnivisualizer and gynaescope with disappointing 
23-25results . Our best bet is still the cervical cytology 
but since there is no organized screening service, 
selective screening of women at high risk using our 
risk assessment score approach (score >16) may be a 
viable alternative in the interim. This way the 
limited resources can be targeted to those women at 
greatest risk of cervical cancer and probably a 
significant reduction in incidence of invasive 
disease may be seen in the not too distant future.
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